Shuyan Meng

482 total citations
20 papers, 356 citations indexed

About

Shuyan Meng is a scholar working on Biomaterials, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shuyan Meng has authored 20 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Biomaterials, 7 papers in Cancer Research and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shuyan Meng's work include Nanoparticle-Based Drug Delivery (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Nanoplatforms for cancer theranostics (4 papers). Shuyan Meng is often cited by papers focused on Nanoparticle-Based Drug Delivery (6 papers), Lung Cancer Treatments and Mutations (5 papers) and Nanoplatforms for cancer theranostics (4 papers). Shuyan Meng collaborates with scholars based in China, Australia and Germany. Shuyan Meng's co-authors include Wei Zhou, Yongmei Ding, Qinghua Xu, Wěi Li, Liang Tang, Wen Hu, Chuanglong He, Zheng‐Ming Huang, Bo Su and Hui Liu and has published in prestigious journals such as The Science of The Total Environment, Nanotechnology and Biogeochemistry.

In The Last Decade

Shuyan Meng

20 papers receiving 350 citations

Peers

Shuyan Meng
Jane Rogan United Kingdom
Yusuke Ohara Japan
Wei-Lun Sun Taiwan
J Whittaker United States
Bojana Milojkovic Kerklaan Netherlands
Dong‐Ha Bhang South Korea
Grace Cui United States
Ryuta Sato Japan
B. Bandstra United States
R. Adinin United States
Jane Rogan United Kingdom
Shuyan Meng
Citations per year, relative to Shuyan Meng Shuyan Meng (= 1×) peers Jane Rogan

Countries citing papers authored by Shuyan Meng

Since Specialization
Citations

This map shows the geographic impact of Shuyan Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuyan Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuyan Meng more than expected).

Fields of papers citing papers by Shuyan Meng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuyan Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuyan Meng. The network helps show where Shuyan Meng may publish in the future.

Co-authorship network of co-authors of Shuyan Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Shuyan Meng. A scholar is included among the top collaborators of Shuyan Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuyan Meng. Shuyan Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Haiyan, Shuyan Meng, Yong-He Han, et al.. (2025). Mechanistic insights into enhanced rare earth element phytoextraction by Dicranopteris pedata in leached soils: Integrating rhizosphere DGT-LA-ICP-MS imaging and metabolomic profiling. The Science of The Total Environment. 1002. 180635–180635. 1 indexed citations
2.
3.
Sun, Hui, et al.. (2024). METTL14 enhances the m6A modification level of lncRNA MSTRG.292666.16 to promote the progression of non-small cell lung cancer. Cancer Cell International. 24(1). 61–61. 7 indexed citations
4.
5.
6.
Xu, Qinghua, Hui Liu, Shuyan Meng, et al.. (2019). First-line continual EGFR-TKI plus local ablative therapy demonstrated survival benefit in EGFR-mutant NSCLC patients with oligoprogressive disease. Journal of Cancer. 10(2). 522–529. 44 indexed citations
7.
Yu, Jia, Qiyu Fang, & Shuyan Meng. (2018). Knockdown of Long Noncoding RNA ENST457720 Inhibits Proliferation of Non-Small Cell Lung Cancer Cells In Vitro and In Vivo. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 27(1). 47–53. 10 indexed citations
8.
9.
Li, Wei, Shuyan Meng, Wei Zhou, et al.. (2018). Dual integrin αvβ 3 and NRP-1-Targeting Paramagnetic Liposome for Tumor Early Detection in Magnetic Resonance Imaging. Nanoscale Research Letters. 13(1). 18 indexed citations
10.
Xu, Qinghua, Xiu Chen, Danwen Qian, et al.. (2014). Treatment and prognostic analysis of patients with leptomeningeal metastases from non‐small cell lung cancer. Thoracic Cancer. 6(4). 407–412. 19 indexed citations
11.
Xu, Qinghua, Yang Wang, Shuyan Meng, et al.. (2013). Treatment outcome for patients with primary NSCLC and synchronous solitary metastasis. Clinical & Translational Oncology. 15(10). 802–809. 27 indexed citations
12.
Zhou, Wei, et al.. (2011). The anti-tumor effects of lung cancer-targeting long-circulating paclitaxel-containing liposomes. Tumori. 31(3). 203–209. 2 indexed citations
13.
Yi, Xianghua, Yongmei Ding, Yu Zeng, et al.. (2011). Magnetic Resonance Imaging Contrast Agent: cRGD-Ferric Oxide Nanometer Particle and Its Role in the Diagnosis of Tumor. Journal of Nanoscience and Nanotechnology. 11(5). 3800–3807. 3 indexed citations
14.
Li, Wei, Bo Su, Shuyan Meng, et al.. (2011). RGD-targeted paramagnetic liposomes for early detection of tumor: In vitro and in vivo studies. European Journal of Radiology. 80(2). 598–606. 24 indexed citations
15.
Cheng, Xiang, Shuyan Meng, Jie Deng, Weifeng Lai, & Huayan Wang. (2011). Identification and characterization of theOct4extended transcriptional regulatory region in Guanzhong dairy goat. Genome. 54(10). 812–818. 4 indexed citations
16.
Meng, Shuyan. (2010). Construction of cRGD-iron oxide nanoparticles and its application in the tumor diagnosis by magnetic resonance imaging. Tumori. 1 indexed citations
17.
Meng, Shuyan, Wěi Li, Yongmei Ding, et al.. (2010). Enhanced antitumor effect of novel dual-targeted paclitaxel liposomes. Nanotechnology. 21(41). 415103–415103. 49 indexed citations
18.
Meng, Shuyan, Bo Su, Wěi Li, et al.. (2010). Integrin-targeted paclitaxel nanoliposomes for tumor therapy. Medical Oncology. 28(4). 1180–1187. 42 indexed citations
19.
Zhou, Caicun, Liang Tang, Xiao‐Jun Yang, et al.. (2010). [Drug resistance mechanism of non small cell lung cancer PC9/AB2 cell line with acquired drug resistance to gefitinib].. PubMed. 33(5). 354–8. 4 indexed citations
20.
Hu, Wen, Zheng‐Ming Huang, Shuyan Meng, & Chuanglong He. (2009). Fabrication and characterization of chitosan coated braided PLLA wire using aligned electrospun fibers. Journal of Materials Science Materials in Medicine. 20(11). 2275–2284. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane Rogan Breakdown of academic impact, for papers by Yusuke Ohara Breakdown of academic impact, for papers by Wei-Lun Sun Breakdown of academic impact, for papers by J Whittaker Breakdown of academic impact, for papers by Bojana Milojkovic Kerklaan Breakdown of academic impact, for papers by Dong‐Ha Bhang Breakdown of academic impact, for papers by Grace Cui Breakdown of academic impact, for papers by Ryuta Sato Breakdown of academic impact, for papers by B. Bandstra Breakdown of academic impact, for papers by R. Adinin
Rankless by CCL
2026